Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Healthcare Stocks To Consider - October 17th - Markets Daily
Johnson & Johnson $JNJ Stock Sold by First Merchants Corp - Markets Daily
Johnson & Johnson $JNJ Stock: Guyasuta Investment Advisors Inc. Decreases Stake - Markets Daily
Community Financial Services Group LLC Buys 3,745 Shares of Johnson & Johnson $JNJ - Stock Observer
Johnson & Johnson Just Raised Its Sales Outlook Again. Here's Why the Dividend King Is Still a Buy. - AOL
Johnson & Johnson $JNJ Position Boosted by Assenagon Asset Management S.A.
Former J&J site cleared for £31m redevelopment
Targeted oral peptides could reshape how precision prescription medicines reach patients
Healthcare Stocks To Add to Your Watchlist - October 16th - Stock Observer
J&J Says CHMP Recommends Approval Of TALVEY Combo In Earlier Line Treatment Of R/R Multiple Myeloma
Does Raised 2026 Outlook Change The Bull Case For Johnson & Johnson (JNJ)?
Johnson & Johnson $JNJ Stock Sold by Ninety One UK Ltd
Johnson & Johnson $JNJ Stock Sold by Fort Washington Investment Advisors Inc. OH - Zolmax
Fort Washington Investment Advisors Inc. OH Sells 539,918 Shares of Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Stock: ZWJ Investment Counsel Inc. Boosts Holdings - Daily Political
Johnson & Johnson $JNJ Stock Sold by Curated Wealth Partners LLC - Stock Observer
Johnson & Johnson $JNJ Stock Sold by State of Alaska Department of Revenue - Daily Political
Johnson & Johnson $JNJ Shares Sold by Ninety One North America Inc. - Daily Political
3 Companies Raising Guidance This Earnings Season
Here's our monthly update on our 32 stocks, including 2 more names to buy
Procter & Gamble Has Raised Its Dividend for 70 Years. These 4 Stocks Also Reward Patience
Pharmaceutical Stocks To Keep An Eye On - October 15th - Zolmax
Leaning Into Energy Stocks as Midterm Elections Draw Near
Johnson & Johnson and Protagonist Therapeutics Icotyde: The Best Inventions of 2026
Healthcare Stocks To Consider - October 15th - Daily Political
Morgan Stanley Has Lowered Expectations for Johnson & Johnson (NYSE:JNJ) Stock Price - Daily Political
Johnson & Johnson (JNJ) To Go Ex-Dividend on November 24th - Stock Observer
Johnson & Johnson $JNJ Stock Bought by Sanders Morris Harris LLC
Johnson & Johnson $JNJ Stock Purchased by Columbus Macro LLC
Johnson & Johnson $JNJ Stock: Cliftonlarsonallen Wealth Advisors LLC Boosts Position
FY2026 EPS Estimate for Johnson & Johnson Lowered by Analyst - Markets Daily
Johnson & Johnson $JNJ Stock Bought by Mather Group LLC. - Daily Political
4,087 Johnson & Johnson $JNJ Shares Bought by First Pacific Financial - Daily Political
33,173 Capital Group Core Balanced ETF $CGBL Shares Bought by Johnson Bixby & Associates LLC - Daily Political
Combination therapy for BCG-unresponsive non-muscle-invasive bladder cancer: biological rationale and ongoing clinical strategies
JNJ Maintains Rating by Leerink Partners -- Price Target Lowered
Johnson & Johnson $JNJ Stock: Thurston Springer Miller Herd & Titak Inc. Lowers Position
Johnson & Johnson $JNJ Stock Sold by Generate Investment Management Ltd
Johnson & Johnson $JNJ Holdings Trimmed by Generate Investment Management Ltd
Royal Bank Of Canada Issues Pessimistic Forecast for Johnson & Johnson (NYSE:JNJ) Stock Price
Top Healthcare Stocks To Research - October 14th - Stock Observer
Johnson & Johnson $JNJ Stake Lifted by First Citizens Bank & Trust Co. - Zolmax
Johnson & Johnson (JNJ) Stock Dropped, What Is Behind The Latest Attention? - Simply Wall St News
22,136 Johnson & Johnson $JNJ Shares Acquired by First Citizens Bank & Trust Co.
Blockbuster Drugs Come and Go. These 5 Pharma Dividend Stocks Keep Paying
Will New Business Development VP Hire and Lens Expansion Strategy Change STAAR Surgical's (STAA) Narrative
Comparing Fortress Biotech (NASDAQ:FBIO) and Johnson & Johnson (NYSE:JNJ) - Stock Observer
5,122 Johnson & Johnson $JNJ Shares Sold by Perpetual Ltd
Promising Pharmaceutical Stocks To Follow Now - October 11th - Markets Daily
Johnson & Johnson stock rout: What's driving the sharp decline?
Promising Healthcare Stocks To Keep An Eye On - October 11th - Stock Observer
Johnson & Johnson Reports Strong Q3 Earnings Amidst Middle East Conflict Impacting Medical Device Sales, ETPharma
Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial
Johnson & Johnson (NYSE:JNJ) Releases FY 2026 Earnings Guidance
Johnson & Johnson $JNJ Stock: Courier Capital LLC Cuts Stake
UnitedHealth vs. Johnson & Johnson: Which Stock Is the Better Buy After Q3 Earnings?
Bank Earnings Get a Cool Reception as Chip Jitters Linger
Johnson & Johnson (NYSE:JNJ) Stock to Pay Quarterly Dividend of $1.34 - Zolmax
Johnson & Johnson (NYSE:JNJ) Shareholders Set to Receive $1.34 Quarterly Dividend
Johnson & Johnson Stocks Fall 4.7% Despite Higher Full-Year Guidance
Johnson & Johnson $JNJ Stock: Contravisory Investment Management Inc. Raises Stake - Stock Observer
J&J falls 6% on an imperfect quarter. Why this is a good chance to buy
Dow Jones Top Company Headlines at 1 PM ET: JPMorgan, Goldman Profit Jumps as Banks Kick Off Earnings | J&J ... | Morningstar
Johnson & Johnson $JNJ Stock Position Increased by Sax Wealth Advisors LLC
Johnson & Johnson Earnings: Pharma Momentum, but MedTech Headwinds Dampen Growth | Morningstar
Johnson & Johnson (JNJ) Q3 Earnings Beat but Shares Drop on MedT
JNJ Stock: Robotic Surgery Push and Q3 Growth Fuel Uptrend
Johnson & Johnson (NYSE:JNJ) Issues FY 2026 Earnings Guidance - Daily Political
J&J's medtech business slows again in Q3
Johnson & Johnson (NYSE:JNJ) Stock Price Down 5.2% - What's Next?
Johnson & Johnson stock falls despite strong earnings as investors focus on medtech unit
Johnson & Johnson Stock Falls 5% After Q3 Profit Plunges
What Johnson & Johnson (JNJ) Said on Its Q3 Earnings Call
Johnson & Johnson Drops 5% as One-Time Charges Overshadow Raised Full-Year Outlook; Eli Lilly Dips, Pfizer Sits Out the Selloff
Johnson & Johnson (JNJ) Stock: Plunges 5% Despite Strong Q3 Earnings
Wall Street subdued in choppy trade after bank earnings
Dow Jones Top Company Headlines at 11 AM ET: JPMorgan, Goldman Profit Jumps as Banks Kick Off Earnings | J&J ... | Morningstar
Why this drug could become 'better than a $10B product': Johnson & Johnson CFO
Johnson & Johnson (NYSE:JNJ) Posts Quarterly Earnings Results, Beats Estimates By $0.07 EPS - Zolmax
$8,550 a Month and Zero Bonds: The Dividend Portfolio Retirees Are Building Instead
Dow Jones Top Company Headlines at 9 AM ET: JPMorgan, Goldman Profit Jumps as Banks Kick Off Earnings | J&J ... | Morningstar
Johnson & Johnson plans to spin off Depuy operations next year
Goldman Beats, JPMorgan Misses: 8 Key Items Shaping the Stock Market Tuesday
Johnson & Johnson (NYSE:JNJ) Releases Earnings Results, Beats Expectations By $0.07 EPS
Exclusive | Carefree panty liners face lawsuit over dangerous carcinogenic claim
Johnson & Johnson Q3 Profit Plunges, Lifts FY26 Outlook; Stock Drops
Johnson & Johnson Q3 Profit Declines, Lifts FY26 Outlook; Stock Drops
J&J beats earnings estimates
Genmab Reports $4.24 Billion In Third-Quarter DARZELEX Sales, Up Year Over Year
Johnson & Johnson CFO Joseph Wolk on the company's Q3 results
4 Dividend Kings Retirees Can Buy and Hold Forever: Safe Income for the Next 60 Years
Dow Jones Top Company Headlines at 7 AM ET: J&J Is Leaning Toward Spinning Out Its Hips-And-Knees Business | UnitedHealth ... | Morningstar
10,574 Johnson & Johnson $JNJ Shares Acquired by NorthCrest Asset Manangement LLC
